23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
357.95%
Revenue growth of 357.95% vs. zero growth in Insurance - Life. Walter Schloss might still want to see if it can translate into profits.
357.95%
Gross profit growth of 357.95% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that could be built upon.
27.87%
Positive EBIT growth while Insurance - Life median is negative. Peter Lynch might see a strong competitive advantage in operations.
27.87%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
30.99%
Positive net income growth while Insurance - Life median is negative. Peter Lynch would view this as a notable competitive advantage.
31.00%
Positive EPS growth while Insurance - Life median is negative. Peter Lynch might see a strong advantage in per-share earnings compared to peers.
31.00%
Positive diluted EPS growth while Insurance - Life median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.71%
Positive OCF growth while Insurance - Life median is negative. Peter Lynch might see a strong relative advantage in operational efficiency.
12.71%
Positive FCF growth while Insurance - Life median is negative. Peter Lynch might view this as a notable advantage over peers.
-4.39%
Negative 10Y revenue/share CAGR while Insurance - Life median is 44.30%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-36.87%
Negative 5Y CAGR while Insurance - Life median is 24.76%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-67.23%
Negative 3Y CAGR while Insurance - Life median is 1.37%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
105.97%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 4.50% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
16.80%
OCF/share CAGR of 16.80% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
-3.40%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
677.95%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 13.15% over a decade. Joel Greenblatt might see a standout compounder of earnings.
7.27%
Positive 5Y CAGR while Insurance - Life median is negative. Peter Lynch sees a notable advantage vs. peers struggling to grow net income/share.
117.93%
Positive 3Y CAGR while Insurance - Life median is negative. Peter Lynch sees a big short-term advantage vs. peers struggling with profit declines.
122.59%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 0.88% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
26.41%
5Y equity/share CAGR of 26.41% while Insurance - Life median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
9.21%
Positive short-term equity/share CAGR while Insurance - Life is negative. Peter Lynch finds a relative advantage vs. sector-level slowdown.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.46%
AR growth of 0.46% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
1.73%
We expand assets while Insurance - Life is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
0.91%
Positive BV/share change while Insurance - Life median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
3.91%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
3.09%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.